• Smarter Starts, Stronger Trials: How Data is Driving Faster Site Activation

    Clinical Research News | Feasibility, site selection, and study startup remain some of the most time-consuming and unpredictable phases of drug development. They are also tightly interconnected, making even small delays or inefficiencies during this period especially impactful, rippling across a study’s timeline and budget and affecting site relationships and patient access.

    Jul 11, 2025

  • Scope of Things: Pragmatic Trials’ Growing Importance

    Clinical Research News | The growing importance of pragmatic clinical trials in healthcare research cannot be overstated. In the most recent episode of the Scope of Things podcast, host Deborah Borfitz speaks with Bethany Kwan, University of Colorado Anschutz Medical Campus, and Heather Smyth, Colorado School of Public Health. Together they explore the fundamental distinctions between traditional clinical trials and pragmatic research approaches, uncovering why this methodology is experiencing such significant growth in modern healthcare research.

    Jul 9, 2025

  • ICH E6(R3) Guidance: Elevating Trials through Collaboration

    Clinical Research News | After 15 years of development, Stanford University's Tom Soh is preparing to take his biosensor technology from laboratory rats to human volunteers. The device, which can continuously monitor molecules in flowing blood for up to seven days, represents a potential paradigm shift in clinical medicine.

    Jul 3, 2025

  • Stanford's Blood Flow Biosensor Heads to Human Trials

    Clinical Research News | After 15 years of development, Stanford University's Tom Soh is preparing to take his biosensor technology from laboratory rats to human volunteers. The device, which can continuously monitor molecules in flowing blood for up to seven days, represents a potential paradigm shift in clinical medicine.

    Jul 2, 2025

  • Walgreens ‘Built the Vessel’ for Making Clinical Trials a Care Option

    Clinical Research News | In the span of three years, Walgreens—an integral part of communities across the U.S. for well over a century—has positioned itself as a key player in the clinical trial ecosystem highlighted by more than 35 biopharma partnerships and the engagement of over 17 million customers participating in industry-sponsored studies. The thesis that co-locating trials where patients are “actually works."

    Jul 1, 2025

  • Follow the Money: Migraine Therapy, Reducing Trial Failure, More

    Clinical Research News | Salvia plans to further develop MySalvia Therapy in a multi-center, double-blind, sham-controlled study for people with chronic migraine; Vivodyne plans to scale its robotics+AI approach to testing on thousands of lab-grown, fully-functional human tissues, which aim to reduce human clinical trial failure; and more.

    Jun 25, 2025